Does TICAGRELOR Cause Myelofibrosis? 17 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 17 reports of Myelofibrosis have been filed in association with TICAGRELOR (Ticagrelor). This represents 0.1% of all adverse event reports for TICAGRELOR.
17
Reports of Myelofibrosis with TICAGRELOR
0.1%
of all TICAGRELOR reports
0
Deaths
2
Hospitalizations
How Dangerous Is Myelofibrosis From TICAGRELOR?
Of the 17 reports, 2 (11.8%) required hospitalization, and 7 (41.2%) were considered life-threatening.
Is Myelofibrosis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TICAGRELOR. However, 17 reports have been filed with the FAERS database.
What Other Side Effects Does TICAGRELOR Cause?
Dyspnoea (3,156)
Myocardial infarction (1,749)
Death (1,510)
Off label use (1,084)
Fatigue (1,081)
Chest pain (1,075)
Contusion (970)
Dizziness (811)
Vascular stent thrombosis (700)
Haemorrhage (676)
What Other Drugs Cause Myelofibrosis?
RUXOLITINIB (1,316)
ELTROMBOPAG (89)
ROMIPLOSTIM (89)
HYDROXYUREA (88)
IMATINIB (76)
DEFERASIROX (57)
MOMELOTINIB (51)
ASPIRIN (46)
RITUXIMAB (43)
ANAGRELIDE (41)
Which TICAGRELOR Alternatives Have Lower Myelofibrosis Risk?
TICAGRELOR vs TICLOPIDINE
TICAGRELOR vs TIGECYCLINE
TICAGRELOR vs TIKOSYN
TICAGRELOR vs TILDRAKIZUMAB
TICAGRELOR vs TILDRAKIZUMAB-ASMN